prof. dr. P.M. van Hagen

Medicine & Life Sciences

1. Graves Ophthalmopathy 100%
2. Primary Immunodeficiency Diseases 73%
3. Common Variable Immunodeficiency 71%
4. Uveitis 58%
5. T-Lymphocytes 48%
6. Proteomics 45%
7. Type 1 Hyper-IgM Immunodeficiency Syndrome 43%
8. Immunoglobulins 43%
9. Immunoglobulin A 42%
10. CCR10 Receptors 42%
11. Immunity 39%
12. Immunoglobulin G 36%
13. Fibroblasts 36%
14. Systematic Reviews 36%
15. Immunoglobulin M 34%
16. Passive Immunization 32%
17. Infections 32%
18. Chromosome Deletion 31%
19. Latent Tuberculosis 31%
20. Serum 31%
21. Adalimumab 30%
22. Connective Tissue Diseases 29%
23. Antiphospholipid Syndrome 29%
24. Antibiotic Prophylaxis 28%
25. Histone Deacetylases 28%
26. Allergy and Immunology 26%
27. Therapeutics 25%
28. Prednisolone 25%
29. Phosphatidylinositol 3-Kinase 24%
30. G-Protein-Coupled Receptors 24%
31. DNA Methylation 24%
32. Liposomes 24%
33. Extracellular Matrix 23%
34. Mast Cells 23%
35. Type 2C Congenital disorder of glycosylation 23%
36. High-Throughput Nucleotide Sequencing 23%
37. SARS Virus 23%
38. B-Lymphocytes 23%
39. Inflammatory Bowel Diseases 23%
40. Antibody Formation 22%
41. Reference Values 21%
42. Retina 21%
43. Antibodies 20%
44. Gain of Function Mutation 19%
45. Observational Studies 19%
46. Steroids 18%
47. Meta-Analysis 18%
48. Cohort Studies 17%
49. Anti-Bacterial Agents 17%
50. Genome 16%